Noom Med vs Calibrate 2026: GLP-1 Weight Loss Programs Compared
Noom Med and Calibrate both pair GLP-1 medication with premium coaching for weight loss. We compare pricing, coaching philosophies, clinical evidence, medication access, and contracts side-by-side — and show where a medication-focused provider like Trimi fits in.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Our team updates competitor reviews when pricing, medication access, or program structures change so patients can compare options with current data.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections guide.
More on GLP-1 Provider Comparisons
Noom vs Calibrate for Weight Loss: What You Need to Know
If you are comparing noom vs calibrate for GLP-1 weight loss, you are choosing between two coaching-heavy telehealth programs that pair prescription medication with structured behavioral support. Noom Med combines semaglutide prescriptions with its behavioral psychology app, while Calibrate delivers a year-long metabolic health coaching program alongside GLP-1 medication. Both charge premium prices because they bundle coaching into the cost of treatment, and both target patients who want more than just a prescription.
Noom Med vs Calibrate, defined: Noom Med is the prescription arm of Noom, the popular weight loss app known for its cognitive behavioral therapy approach to food and habits, now expanded to include GLP-1 medications. Calibrate is a standalone telehealth company built around a 12-month metabolic reset program that combines GLP-1 medication with intensive coaching across food, exercise, sleep, and emotional health. Both are legitimate telehealth providers with licensed medical teams, but they differ meaningfully in coaching philosophy, pricing structure, contract terms, and overall cost.
The central question for most patients is whether the coaching bundled into these programs justifies the premium price over a medication-focused provider. Clinical trial data shows that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9% body weight loss with semaglutide at 68 weeks, with both the treatment and placebo groups receiving lifestyle counseling (Wilding et al., NEJM, 2021). The coaching both groups received contributed roughly the same amount, while the medication accounted for the difference in outcomes. Patients who want effective GLP-1 therapy without paying a coaching premium may prefer a provider like Trimi, which offers semaglutide at $99 per month and tirzepatide at $125 per month with clinical oversight included.
Noom Med vs Calibrate vs Trimi: Side-by-Side Comparison
| Feature | Noom Med | Calibrate | Trimi |
|---|---|---|---|
| Semaglutide monthly cost | $149--$209/mo | $1,649/yr program + medication | $99/mo |
| Tirzepatide monthly cost | Limited availability | $1,649/yr program + medication | $125/mo |
| Additional app/coaching fee | $32--$70/mo possible | Included in program fee | None |
| Coaching model | App-based CBT + psychology | 1-on-1 metabolic health coaching | Clinical guidance |
| Medication included in price | Yes (med subscription) | Often separate from program fee | Yes |
| Flat dose-independent pricing | No | No | Yes |
| Lab work required | No | Yes (metabolic panel) | No (recommended when indicated) |
| Provider visits included | Yes | Yes | Yes |
| Contract commitment | Varies by plan | 12 months | None (month-to-month) |
| Cancellation penalties | Possible | Yes (early termination) | None |
| Estimated 12-month total | $2,172--$3,348 | $3,000--$6,000+ | $1,188 |
| Best for | Patients who value behavioral psychology app alongside medication | Patients wanting intensive year-long metabolic coaching + insurance med access | Patients wanting the best value for clinical GLP-1 care |
All pricing is approximate and based on publicly available information as of April 2026. Noom Med's effective monthly total includes the potential additional Noom app subscription fee. Calibrate's total varies significantly based on insurance coverage for medication. Verify current pricing directly with each provider before enrolling.
Pricing Breakdown: What You Actually Pay
Cost is the most consequential difference between Noom Med and Calibrate for most patients, and both programs have pricing structures that are more complex than a single monthly number. Understanding the full financial commitment before enrolling is essential, because neither program is inexpensive and the total annual costs can differ by thousands of dollars.
Noom Med Pricing
Noom Med charges $149 to $209 per month for its semaglutide medication subscription, covering the prescription, clinical oversight, and medication delivery. However, the Noom coaching app is a separate product with its own subscription fee of $32 to $70 per month depending on the plan and billing cycle. Some patients report bundled pricing that reduces the combined cost, but the total effective monthly expense for Noom Med with full coaching access typically ranges from $181 to $279 per month for semaglutide. Over 12 months, that totals $2,172 to $3,348 for medication and coaching combined. Tirzepatide availability through Noom Med is limited, and pricing for it may differ. For a detailed look at potential issues, see our guide on Noom Med side effects.
Calibrate Pricing
Calibrate charges a program fee of approximately $1,649 per year for the full metabolic reset program, which can be paid as a lump sum or in monthly installments. This program fee covers the coaching, structured curriculum, metabolic lab work coordination, and provider consultations. Critically, the GLP-1 medication cost is often separate from the program fee. Calibrate has primarily worked with brand-name GLP-1 medications through insurance pathways. If insurance covers the medication, patients pay their copay on top of the program fee. If insurance does not cover the medication, patients face brand-name prices that can exceed $1,000 per month in addition to the program fee. In the worst case, a Calibrate patient without medication insurance could pay $3,000 to $6,000 or more annually for program plus medication combined. For details on potential issues with Calibrate's program, see our Calibrate side effects guide.
Trimi Pricing
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide. The price is flat and dose-independent, meaning you pay the same amount whether you are on a starting dose or a maintenance dose. There are no additional fees for app access, coaching, consultations, or shipping. The 12-month total for semaglutide at Trimi is $1,188 with no risk of price escalation. Compared to Noom Med's midpoint cost of approximately $2,760 and Calibrate's minimum of approximately $3,000, Trimi saves patients $1,572 to $4,812 or more annually. For a comprehensive comparison of affordable GLP-1 options, see our cheapest GLP-1 injections 2026 guide.
Annual Cost Perspective
GLP-1 therapy is typically sustained for 12 to 24 months or longer for optimal results. Small monthly differences compound into significant annual savings. A patient choosing Trimi over Noom Med saves roughly $1,000 to $2,100 per year. A patient choosing Trimi over Calibrate saves $1,800 to $4,800 or more per year depending on insurance status. These savings can be redirected toward nutrition, exercise, or other health investments that support your weight loss goals.
Coaching Philosophies: Behavioral Psychology vs Metabolic Reset
The coaching component is what distinguishes both Noom Med and Calibrate from medication-focused providers. Both platforms charge a significant premium for coaching, but their approaches differ meaningfully in philosophy, structure, and delivery. Understanding these differences helps you decide whether either coaching model justifies its cost for your situation.
Noom Med Coaching
Rooted in cognitive behavioral therapy (CBT) principles
App-based daily lessons on food psychology and habit formation
Color-coded food classification system (green, yellow, red)
Daily calorie logging and meal tracking within the Noom app
Group coaching with other Noom users and optional 1-on-1 sessions
Focus on changing your psychological relationship with food
Self-directed pace through app curriculum modules
Calibrate Coaching
Structured 12-month metabolic reset curriculum
Dedicated 1-on-1 health coach assigned to each patient
Four-pillar framework: food, exercise, sleep, emotional health
Metabolic lab work to establish baselines and track progress
Sequenced modules patients progress through over the year
Focus on resetting the body's metabolic set point holistically
Provider-guided pace with defined program milestones
Noom Med's coaching is better suited for patients who want a technology-driven, self-paced behavioral psychology program they can engage with on their phone throughout the day. The CBT foundation is evidence-informed and particularly strong for patients who struggle with emotional eating, food guilt, or deeply ingrained eating patterns. Calibrate's coaching is more clinically structured and comprehensive, with a dedicated coach guiding patients through a defined curriculum that addresses not just food but exercise, sleep, and stress management as interconnected metabolic factors.
Calibrate's approach has genuine clinical merit for patients with complex metabolic profiles or multiple failed weight loss attempts who need the accountability and structure of a guided year-long program. Noom Med's approach has merit for patients who prefer digital self-directed learning and want the behavioral psychology toolkit alongside their medication. The honest question for both programs is whether you will consistently engage with the coaching tools over 12 or more months, or whether your engagement will taper after the initial motivation fades.
The coaching premium question
Both Noom Med and Calibrate charge significantly more than medication-focused providers because of their coaching components. Research consistently shows that GLP-1 medication drives the majority of weight loss outcomes. Patients who are self-motivated, already knowledgeable about nutrition and exercise, or unlikely to engage daily with coaching tools for a full year may get equivalent clinical results at substantially lower cost with a medication-focused provider like Trimi.
Clinical Evidence: What Actually Drives Weight Loss
Neither Noom Med nor Calibrate has published peer-reviewed clinical trials demonstrating that their specific coaching programs produce weight loss outcomes superior to GLP-1 medication with standard clinical oversight. The evidence base for GLP-1 weight loss comes from large-scale randomized controlled trials of the medications themselves, not from any individual platform's coaching methodology. This distinction matters because both programs charge a premium specifically for coaching, yet the evidence attributes the majority of weight loss to the medication.
Semaglutide: STEP 1 Trial Results
The STEP 1 trial enrolled 1,961 adults and demonstrated that semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks, compared to 2.4% with placebo. Both groups received lifestyle counseling, meaning the medication — not the counseling — drove the 12.5 percentage point difference (Wilding et al., New England Journal of Medicine, 2021). This is the foundational evidence supporting every semaglutide-based program, including Noom Med, Calibrate, and Trimi.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults and demonstrated that tirzepatide produced up to 22.5% body weight loss at the highest dose over 72 weeks, compared to 3.1% with placebo. Both groups received lifestyle counseling. The dual GIP/GLP-1 mechanism of tirzepatide produced even greater weight loss than semaglutide alone (Jastreboff et al., New England Journal of Medicine, 2022). Trimi offers tirzepatide at $125 per month; Calibrate may offer it through insurance pathways; Noom Med's tirzepatide availability is limited.
Intensive Coaching vs Standard Counseling
A study by Wadden et al. compared semaglutide plus intensive behavioral therapy against semaglutide with standard counseling. Both groups achieved significant weight loss, and the intensive therapy group did not demonstrate a clinically meaningful advantage over the standard counseling group. This finding is directly relevant to the Noom Med and Calibrate pricing discussion: their intensive coaching programs may not produce materially better outcomes than basic clinical guidance alongside GLP-1 medication.
SELECT Cardiovascular Trial
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and established cardiovascular disease (Lincoff et al., New England Journal of Medicine, 2023). This cardiovascular benefit is attributable to the medication itself, independent of any coaching methodology, further reinforcing that the pharmacological intervention is the primary therapeutic driver.
The evidence is consistent: GLP-1 medications produce substantial, clinically meaningful weight loss and cardiovascular benefits. Coaching and behavioral support are beneficial for overall health and habit formation, but they are not the primary mechanism of weight loss in GLP-1 treatment. Patients should evaluate whether the coaching premiums charged by Noom Med and Calibrate align with their individual needs and budget, knowing that the medication accounts for the vast majority of expected clinical outcomes.
Medication Options and Access
All three providers prescribe semaglutide for weight loss. The medication works through the same GLP-1 receptor agonist mechanism regardless of which provider prescribes it, and produces the same pharmacological effects and side effect profile. The differences are in medication type availability, formulation (brand-name vs compounded), and how medication cost is structured.
Noom Med medications
Primarily semaglutide. Tirzepatide availability is limited and may vary. Compounded and brand-name options may be available depending on supply and market conditions.
Calibrate medications
Has historically focused on brand-name GLP-1 medications accessed through insurance. Medication cost may be separate from the program fee, creating variable total cost depending on insurance coverage.
Trimi medications
Semaglutide ($99/mo) and tirzepatide ($125/mo). Compounded formulations from FDA-registered 503B pharmacies. Flat pricing at all doses with medication, consultation, and shipping included.
Calibrate's insurance-first approach works well for patients with strong GLP-1 coverage, potentially reducing medication costs to a copay. For the majority of patients paying out of pocket, however, Trimi's compounded formulations offer the same active pharmaceutical ingredients at a fraction of brand-name prices, making sustained long-term treatment financially realistic without insurance dependency. Noom Med sits in between, offering medication through its subscription at $149 to $209 per month for semaglutide, with the added variable of a possible separate Noom app fee.
Who Should Choose Noom Med
Noom Med is the right fit if you specifically value the Noom app's behavioral psychology approach and want to combine cognitive behavioral therapy techniques with GLP-1 medication. Patients who have used the Noom app before and found its color-coded food system and daily lessons helpful may appreciate the continuity of using the same platform with medication added. The app-based, self-paced format suits patients who prefer digital engagement over scheduled coaching calls.
Noom Med is not the right choice if cost efficiency is a priority. At $181 to $279 per month effective cost including the app subscription, Noom Med is substantially more expensive than medication-focused alternatives. Patients who are primarily interested in the medication and unlikely to engage with daily app lessons for months on end are paying for coaching they will not fully use. If you are currently on Noom Med and considering a switch, our guide to canceling Noom Med details the transition process step by step.
Who Should Choose Calibrate
Calibrate is the right fit if you want the most comprehensive, clinically structured weight loss program available and are willing to commit to a full year. The dedicated 1-on-1 coaching, four-pillar metabolic framework, lab work, and sequenced curriculum are genuinely impressive for patients who will fully engage with every component. Insurance navigation may reduce medication costs for patients with GLP-1 coverage, potentially making Calibrate more competitive on total cost.
Calibrate is not the right choice if flexibility, affordability, or fast treatment initiation matter to you. The 12-month contractual commitment means you are locked in even if your needs or finances change. The required lab work and structured onboarding can delay treatment start by several weeks. Without insurance medication coverage, Calibrate becomes the most expensive option by a wide margin. If you are currently on Calibrate and exploring alternatives, our guide to canceling Calibrate covers the process and contract considerations.
Who Should Choose Trimi
Trimi is the right fit if you want effective GLP-1 treatment at the lowest sustainable price without paying a premium for coaching services you may not fully use. Flat pricing ($99/mo semaglutide, $125/mo tirzepatide), no contracts, no hidden fees, and responsive clinical support make Trimi the most financially straightforward option. Access to both semaglutide and tirzepatide at dose-independent pricing means your cost never increases as your treatment progresses through the titration schedule.
Trimi is not the right choice if you specifically want intensive app-based coaching (Noom Med) or a year-long structured metabolic reset program (Calibrate). Trimi's model focuses on clinical medication management and provider oversight rather than comprehensive behavioral programming. The trade-off is clear: patients who choose Trimi save $1,000 to $4,800 or more annually but forgo the coaching platforms that Noom Med and Calibrate provide. For patients who are self-motivated, already knowledgeable about nutrition and exercise, or prefer to supplement their medication with independent lifestyle strategies, this trade-off strongly favors Trimi.
The Bottom Line
Medication drives the clinical outcome, not coaching
GLP-1 medication is the primary cause of weight loss in all three programs. The STEP 1 trial demonstrated 14.9% body weight loss from semaglutide and the SURMOUNT-1 trial demonstrated up to 22.5% from tirzepatide, with coaching contributing a marginal additional benefit at best (Wilding et al., NEJM, 2021; Jastreboff et al., NEJM, 2022). When you pay more at Noom Med or Calibrate, you are primarily paying for coaching, not for a better medical outcome.
Calibrate is the most expensive, Noom Med is mid-range, Trimi costs the least
For semaglutide over 12 months: Calibrate totals $3,000 to $6,000 or more (depending on insurance), Noom Med totals $2,172 to $3,348, and Trimi totals $1,188. The annual savings of $1,000 to $4,800 by choosing Trimi are substantial, especially for a treatment course that often continues for years.
Both coaching programs are well-designed but serve different patients
Noom Med excels at app-based behavioral psychology for self-directed learners. Calibrate excels at structured, clinician-guided metabolic coaching for patients who want maximum accountability. Neither has published evidence showing its coaching produces better weight loss than medication with standard clinical oversight. Choose the coaching model that fits your learning style — or skip the coaching premium entirely if you are self-motivated.
Start with the medication, add coaching if you need it
Rather than starting with an expensive coaching-plus-medication program and downgrading later, consider starting with a cost-effective medication provider like Trimi. If you find you need additional behavioral support after beginning treatment, standalone coaching apps and nutritional counseling are available independently and often at lower cost than the premium bundled by Noom Med or Calibrate.
Frequently Asked Questions
Is Noom Med the same as regular Noom?
No. Regular Noom is a behavioral weight loss app built around cognitive behavioral therapy techniques without medication. Noom Med is a separate clinical arm that pairs GLP-1 medications such as semaglutide with Noom's app-based coaching. Noom Med requires a medical evaluation and prescription, and the medication subscription ($149 to $209 per month) is separate from the optional Noom app subscription ($32 to $70 per month). The two products share branding but differ substantially in scope and cost.
What is Calibrate's metabolic reset?
Calibrate's metabolic reset is a structured, year-long program that combines GLP-1 medication with coaching across four pillars: food, exercise, sleep, and emotional health. The concept is based on the science of metabolic set point theory, which holds that the body defends a particular weight range through hormonal and neurological mechanisms. Calibrate uses medication to address the hormonal component while coaching targets behavioral factors across all four pillars simultaneously. The program includes metabolic lab work, structured curriculum modules, dedicated coaching, and provider oversight for the full 12-month commitment.
Which is more expensive, Noom Med or Calibrate?
Calibrate is generally more expensive overall. Calibrate's program fee starts at approximately $1,649 per year plus separate medication costs, which can bring total annual spending to $3,000 or more depending on insurance and medication source. Noom Med charges $149 to $209 per month for the medication subscription with a possible additional Noom app fee of $32 to $70 per month, totaling approximately $2,172 to $3,348 annually. Both are significantly more expensive than medication-focused providers like Trimi, which charges $99 per month for semaglutide ($1,188 annually).
Does Calibrate require a one-year contract?
Yes. Calibrate requires a 12-month commitment when you enroll. This commitment is contractual, meaning you are responsible for the full program fee even if you decide to leave the program early. The one-year structure is based on clinical evidence that sustained weight loss treatment over 12 or more months produces the best outcomes. However, the contractual nature of the commitment reduces flexibility compared to month-to-month providers. Noom Med's commitment terms vary by plan but are generally more flexible than Calibrate's.
Do I need coaching to lose weight on GLP-1 medication?
Clinical evidence shows that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9 percent body weight loss with semaglutide compared to 2.4 percent with placebo, and both groups received lifestyle counseling (Wilding et al., NEJM, 2021). The coaching that both groups received contributed roughly the same amount. While coaching can support habit formation and long-term sustainability, the medication produces the vast majority of the clinical weight loss effect. Many patients achieve excellent results with medication and standard clinical oversight alone.
Can I switch from Noom Med or Calibrate to a cheaper provider?
Yes. Your medication type and dose transfer without interruption. Complete your new provider's health assessment, share your current treatment history including medication, dose, and any lab results, and the new provider can continue your GLP-1 therapy. The main considerations are timing the switch to avoid a medication supply gap and reviewing any contract terms or cancellation penalties with your current provider. Calibrate's 12-month commitment may involve early termination consequences, so review your agreement carefully before switching.
Does Noom Med offer tirzepatide?
Noom Med has historically focused on semaglutide as its primary GLP-1 medication. Tirzepatide availability through Noom Med is more limited and may vary by region and supply. For patients specifically seeking tirzepatide, Calibrate may offer it through insurance pathways, and Trimi offers compounded tirzepatide at $125 per month with flat pricing regardless of dose. If tirzepatide is your preferred medication, confirm availability directly with Noom Med before enrolling.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024.
- Noom Health, Inc. Noom Med official program and pricing information. 2026.
- Calibrate Health, Inc. Official website and program information. 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Individual results vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details directly with each provider. Pricing information reflects publicly available data as of April 2026 and is subject to change.